Trial Profile
Investigation of the physiological effects of CXCR4 inhibition on the kinetics of radiolabelled neutrophils in man (EPIGRAPH)
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 28 Jun 2016
Price :
$35
*
At a glance
- Drugs Plerixafor (Primary)
- Indications Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Glioma; Sickle cell anaemia; Stem cell mobilisation
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms EPIGRAPH
- 28 Jun 2016 New trial record
- 13 Jun 2016 Planned End Date changed from 1 Oct 2017 to 1 May 2017.